# Medical Cannabis and Epilepsy: Reviewing the Evidence > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-epilepsy-treatment-evidence/ > **Published:** 2026-03-26T02:16:22-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:38:43-04:00 > **Clinical Summary:** Explore cannabis epilepsy treatment evidence focusing on CBD and THC's role in managing drug-resistant seizures and improving patient outcomes. --- CED Clinical Relevance  #72Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. 🔬 Evidence Watch  |  CED Clinic EpilepsyCbdSeizuresPediatricDrug-Resistant Journal British journal of hospital medicine (London, England: 2005) Study Type Clinical Study Population Human participants Why This Matters This review addresses a critical gap in epilepsy care where one-third of patients experience drug-resistant seizures. Given that CBD is now FDA-approved for specific epilepsy syndromes, understanding the broader evidence base helps clinicians navigate treatment options for refractory cases. Clinical Summary This clinical review examines the anticonvulsant properties of cannabis phytocannabinoids, particularly CBD and THC, in treating epilepsy. The authors highlight that approximately 30% of epilepsy patients have medication-resistant seizures, creating a significant unmet medical need. While the evidence base has expanded over recent decades, the review notes persistent reluctance among clinicians and regulatory bodies regarding [cannabis use](https://cedclinic.com/cannabis-cardiovascular-health-insights-2024/) in epilepsy. The authors emphasize the need for better education about cannabis therapeutics to improve patient access to these medicines. Dr. Caplan’s Take “This review reinforces what we’ve seen clinically – CBD can be genuinely helpful for certain epilepsy patients, particularly those with treatment-resistant forms. The regulatory approval of Epidiolex has provided a clear pathway, though access and cost remain significant barriers for many families.” Clinical Perspective 🧠 Clinicians should consider CBD for patients with drug-resistant epilepsy, particularly those with [Dravet syndrome](https://cedclinic.com/cannabidiol-for-epilepsy-treatment-rare-forms/) or Lennox-Gastaut syndrome where evidence is strongest. Patient education about both benefits and limitations is essential, and coordination with neurology specialists familiar with cannabis therapeutics is recommended for optimal outcomes. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Medical%20Cannabis%20and%20Epilepsy%3A%20The%20Evidence.%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41284246/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41284246/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Medical%20Cannabis%20and%20Epilepsy%3A%20The%20Evidence.%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41284246/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41284246/](https://pubmed.ncbi.nlm.nih.gov/41284246/) Table of Contents - [FAQ](#FAQ)[How effective is medical cannabis for treating epilepsy?](#How_effective_is_medical_cannabis_for_treating_epilepsy) - [Which patients with epilepsy might benefit most from medical cannabis?](#Which_patients_with_epilepsy_might_benefit_most_from_medical_cannabis) - [What are the main active compounds in medical cannabis for epilepsy?](#What_are_the_main_active_compounds_in_medical_cannabis_for_epilepsy) - [Why are some clinicians hesitant to prescribe medical cannabis for epilepsy?](#Why_are_some_clinicians_hesitant_to_prescribe_medical_cannabis_for_epilepsy) - [Is medical cannabis safe for long-term epilepsy treatment?](#Is_medical_cannabis_safe_for_long-term_epilepsy_treatment) - [Related](#Related) ## FAQ #### How effective is medical cannabis for treating epilepsy? Research shows that specific phytocannabinoids, particularly cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), possess anticonvulsant properties and have demonstrated effectiveness in treating seizures. The clinical evidence base has been growing over recent decades, establishing both efficacy and safety profiles for cannabis-based epilepsy treatments. #### Which patients with epilepsy might benefit most from medical cannabis? [Medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) may be particularly beneficial for the approximately 30% of epilepsy patients who experience drug-resistant seizures that don’t respond to traditional antiseizure medications. [Cannabis-based treatments](https://cedclinic.com/cannabis-medical-clinic-experience-beyond-smoking-vaping/) appear effective across different age groups, including pediatric patients with treatment-resistant epilepsy. #### What are the main active compounds in medical cannabis for epilepsy? The two primary therapeutic compounds are cannabidiol (CBD) and delta-9-tetrahydrocannabinol (THC), both phytocannabinoids derived from the cannabis plant. These compounds have been specifically shown to have anticonvulsant properties that can help reduce seizure frequency and severity. #### Why are some clinicians hesitant to prescribe medical cannabis for epilepsy? Despite growing clinical evidence, many clinicians and medical regulatory bodies remain reluctant to recommend cannabis for epilepsy patients. This hesitancy appears to stem from the need for more comprehensive education about cannabis’s therapeutic properties and the existing clinical evidence base. #### Is medical cannabis safe for long-term epilepsy treatment? Current research has been establishing safety profiles for cannabis-based epilepsy treatments alongside efficacy data. However, patients should work closely with healthcare providers to monitor for potential side effects and drug interactions, particularly when used in conjunction with other antiseizure medications. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “Medical Cannabis and Epilepsy: The Evidence.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41284246/”, “about”: “british journal hospital medicine london england”, “isPartOf”: “British journal of hospital medicine (London, England: 2005)”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Is Cannabis Effective for Treating Mental Health Disorders? – Labroots](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) Explore the effectiveness of cannabis in mental health treatment, providing insights relevant to neurological conditions like epilepsy. [Read More](https://cedclinic.com/cannabis-mental-health-treatment-challenges/) [New Research Shows Cannabis Compounds May Boost Liver and Heart Health – Muscle & Fitness](https://cedclinic.com/cannabinoids-hepatoprotective-properties-liver-heart-health/) Discover emerging research on [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) that may support overall health, complementing epilepsy treatment considerations. [Learn More](https://cedclinic.com/cannabinoids-hepatoprotective-properties-liver-heart-health/) [Ireland Moves Forward With Review of Medical Cannabis Programme](https://cedclinic.com/ireland-medical-cannabis-programme-review/) Stay updated on [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) program reviews and policy developments that impact patient access and treatment options. [Explore Updates](https://cedclinic.com/ireland-medical-cannabis-programme-review/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).